Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
42,431
Sort by:
2017 Hematology and Flow Cytometry: A Market Facing Regulatory and Competitive Challenges--Advances in Molecular Diagnostics, IT, and Growing Understanding of Immunologic Forces Regulating Systemic Diseases Will Profoundly Impact the Market
US$ 22,050.00
... , Italy, Japan, Spain, UK, USA Worldwide Market Overview Facilities performing hematology and flow cytometry testing by country. Test volume and sales projections by country ... study reviews current instrumentation technologies , and compares features of leading hematology, flow cytometry, platelet aggregation and sedimentation rate analyzers. The report features ...
March 2017
700 pages
2017 Nucleic Acid Testing: Infectious Diseases, Cancer, Genetic Diseases, Forensic Testing, Paternity Testing/HLA Typing--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence
US$ 22,050.00
... test volume and sales forecasts for majorapplications, including:- Infectious Diseases- Forensic Testing- Cancer- Paternity Testing/HLA Typing- Genetic Diseases- Others- Ten-year test ... and other suppliers.- Extensive review of NAT technologies,test formats, detection methodologies, trendsin testing automation and over 30 target/signalamplification methods, including ...
March 2017
1050 pages
2017 Synthes: Strategies, Marketing, R&D, Technologies, Products, Organization
US$ 1,665.00
... strategic assessment of Synthes, one of the worlds leading orthopedics companies, provides significant competitor ... of effective marketing and R&D programs. The report presents a comprehensive analysis of the companys performance, capabilities, goals and strategies in the global orthopedics market. Contains ...
March 2017
30 pages
2017 Chlamydia Diagnostics Market: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment--USA, Europe, Japan--Hospitals, Commercial and Public Health Labs, POC Locations
US$ 855.00
... supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Chlamydia ... , in addition to test volume and sales projections, includes sales and market share estimates for major suppliers of Chlamydia tests.
March 2017
2017 Chancroid Diagnostics Market: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment--US, Europe, Japan--Hospitals, Commercial and Public Health Labs, POC Locations
US$ 540.00
This report presents test volumes and sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Chancroid tests performed in the following market segments: Hospitals Commercial/Private Labs Physician Offices Public Health Labs
March 2017
2017 Europe Cancer Diagnostics Market Segmentation Analysis: Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 17,730.00
... market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market ... of laboratories performing cancer diagnostic testing by country. Cancer statistics, etiology and recent developments in Europe. Business ...
March 2017
820 pages
2017 Future Horizons and Growth Strategies in the Global Blood Banking Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
US$ 31,950.00
... market segmentationanalysis, including review of the marketdynamics, trends, structure, size, growth,and key suppliers by country. Test volume and sales forecasts ...
March 2017
800 pages
2017 Germany Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 6,030.00
... markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ... market dynamics, structure, size, growth and major suppliers. Estimated universe of laboratories performing cancer diagnostic testing. Cancer statistics, etiology and recent developments in Germany. Business ...
March 2017
585 pages
